Filing Details

Accession Number:
0000950170-23-070835
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-12-15 17:31:17
Reporting Period:
2023-12-13
Accepted Time:
2023-12-15 17:31:17
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1756262 Transmedics Group Inc. TMDX Electromedical & Electrotherapeutic Apparatus (3845) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1773663 Miriam Provost C/O Transmedics Group, Inc.
200 Minuteman Road
Andover MA 01810
Vp, Global Regulatory Affairs No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-12-13 415 $16.14 24,026 No 4 M Direct
Common Stock Disposition 2023-12-13 206 $75.10 23,820 No 4 S Direct
Common Stock Acquisiton 2023-12-13 1,632 $66.10 25,452 No 4 M Direct
Common Stock Disposition 2023-12-13 1,509 $75.10 23,943 No 4 S Direct
Common Stock Acquisiton 2023-12-13 3,597 $38.46 27,540 No 4 M Direct
Common Stock Disposition 2023-12-13 2,407 $75.10 25,133 No 4 S Direct
Common Stock Disposition 2023-12-15 1,785 $0.00 23,348 No 4 G Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 G Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2023-12-13 415 $0.00 415 $16.14
Common Stock Stock Option (Right to Buy) Disposition 2023-12-13 1,632 $0.00 1,632 $66.10
Common Stock Stock Option (Right to Buy) Disposition 2023-12-13 3,597 $0.00 3,597 $38.46
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
7,811 2030-02-27 No 4 M Direct
7,073 2033-02-20 No 4 M Direct
7,813 2031-02-24 No 4 M Direct
Footnotes
  1. The exercise followed the sell-to-cover process, whereby a portion of the shares acquired through the exercise were sold in the open market, with the proceeds used to fund the aggregate exercise price of the options.
  2. On December 15, 2023, the reporting person donated 1,785 shares of directly owned common stock to a donor-advised fund, which will use the gifted shares for charitable purposes.
  3. Includes 5,685 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.
  4. The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 27, 2020.
  5. The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 20, 2023.
  6. The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 24, 2021.